Active substance
Results for the substance alectinib
1 result
About this active substance
Alectinib is a medication used for the treatment of non-small cell lung cancer (NSCLC) with ALK (anaplastic lymphoma kinase) gene mutations. It acts as an ALK inhibitor, blocking the growth and spread of cancer cells.
It is administered as oral capsules, usually twice daily, as directed by a doctor. Alectinib is commonly used as a first-line therapy or after the failure of other ALK-inhibitor treatments.
Side effects may include fatigue, constipation, muscle pain, swelling, or elevated liver enzymes. In rare cases, severe reactions such as lung damage or hepatotoxicity may occur.
Patients should be regularly monitored for liver function and other potential adverse reactions. It is important to strictly follow the doctor's recommendations to optimize treatment effectiveness.
It is administered as oral capsules, usually twice daily, as directed by a doctor. Alectinib is commonly used as a first-line therapy or after the failure of other ALK-inhibitor treatments.
Side effects may include fatigue, constipation, muscle pain, swelling, or elevated liver enzymes. In rare cases, severe reactions such as lung damage or hepatotoxicity may occur.
Patients should be regularly monitored for liver function and other potential adverse reactions. It is important to strictly follow the doctor's recommendations to optimize treatment effectiveness.